nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A2—type 2 diabetes mellitus	0.509	1	CbGaD
Thiabendazole—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0724	0.329	CbGbCtD
Thiabendazole—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.057	0.259	CbGbCtD
Thiabendazole—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0539	0.245	CbGbCtD
Thiabendazole—CYP1A2—Losartan—type 2 diabetes mellitus	0.0367	0.167	CbGbCtD
Thiabendazole—Lansoprazole—CYP1A2—type 2 diabetes mellitus	0.00105	0.602	CrCbGaD
Thiabendazole—Lansoprazole—CYP3A4—type 2 diabetes mellitus	0.000694	0.398	CrCbGaD
Thiabendazole—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000395	0.00189	CcSEcCtD
Thiabendazole—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000392	0.00188	CcSEcCtD
Thiabendazole—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000392	0.00188	CcSEcCtD
Thiabendazole—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000391	0.00187	CcSEcCtD
Thiabendazole—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.00039	0.00187	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000389	0.00187	CcSEcCtD
Thiabendazole—Rash—Repaglinide—type 2 diabetes mellitus	0.000389	0.00186	CcSEcCtD
Thiabendazole—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000388	0.00186	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000388	0.00186	CcSEcCtD
Thiabendazole—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000387	0.00185	CcSEcCtD
Thiabendazole—Headache—Repaglinide—type 2 diabetes mellitus	0.000386	0.00185	CcSEcCtD
Thiabendazole—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000385	0.00185	CcSEcCtD
Thiabendazole—Flushing—Metformin—type 2 diabetes mellitus	0.000385	0.00185	CcSEcCtD
Thiabendazole—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000382	0.00183	CcSEcCtD
Thiabendazole—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000378	0.00181	CcSEcCtD
Thiabendazole—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000377	0.00181	CcSEcCtD
Thiabendazole—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000376	0.0018	CcSEcCtD
Thiabendazole—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000376	0.0018	CcSEcCtD
Thiabendazole—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000375	0.0018	CcSEcCtD
Thiabendazole—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000374	0.00179	CcSEcCtD
Thiabendazole—Anorexia—Glyburide—type 2 diabetes mellitus	0.000374	0.00179	CcSEcCtD
Thiabendazole—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000374	0.00179	CcSEcCtD
Thiabendazole—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000373	0.00179	CcSEcCtD
Thiabendazole—Chills—Metformin—type 2 diabetes mellitus	0.000372	0.00179	CcSEcCtD
Thiabendazole—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00037	0.00177	CcSEcCtD
Thiabendazole—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000369	0.00177	CcSEcCtD
Thiabendazole—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000367	0.00176	CcSEcCtD
Thiabendazole—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000367	0.00176	CcSEcCtD
Thiabendazole—Hypotension—Glyburide—type 2 diabetes mellitus	0.000367	0.00176	CcSEcCtD
Thiabendazole—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000367	0.00176	CcSEcCtD
Thiabendazole—Nausea—Repaglinide—type 2 diabetes mellitus	0.000366	0.00175	CcSEcCtD
Thiabendazole—Asthenia—Glipizide—type 2 diabetes mellitus	0.000366	0.00175	CcSEcCtD
Thiabendazole—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000365	0.00175	CcSEcCtD
Thiabendazole—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000365	0.00175	CcSEcCtD
Thiabendazole—Flushing—Irbesartan—type 2 diabetes mellitus	0.000363	0.00174	CcSEcCtD
Thiabendazole—Angioedema—Valsartan—type 2 diabetes mellitus	0.000363	0.00174	CcSEcCtD
Thiabendazole—Pruritus—Glipizide—type 2 diabetes mellitus	0.000361	0.00173	CcSEcCtD
Thiabendazole—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00036	0.00173	CcSEcCtD
Thiabendazole—Angioedema—Orlistat—type 2 diabetes mellitus	0.000358	0.00172	CcSEcCtD
Thiabendazole—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000355	0.0017	CcSEcCtD
Thiabendazole—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000354	0.0017	CcSEcCtD
Thiabendazole—Chills—Irbesartan—type 2 diabetes mellitus	0.000351	0.00168	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000351	0.00168	CcSEcCtD
Thiabendazole—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000351	0.00168	CcSEcCtD
Thiabendazole—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000351	0.00168	CcSEcCtD
Thiabendazole—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00035	0.00168	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000349	0.00167	CcSEcCtD
Thiabendazole—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000349	0.00167	CcSEcCtD
Thiabendazole—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000349	0.00167	CcSEcCtD
Thiabendazole—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000346	0.00166	CcSEcCtD
Thiabendazole—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000345	0.00166	CcSEcCtD
Thiabendazole—Tinnitus—Losartan—type 2 diabetes mellitus	0.000344	0.00165	CcSEcCtD
Thiabendazole—Jaundice—Ramipril—type 2 diabetes mellitus	0.000343	0.00164	CcSEcCtD
Thiabendazole—Flushing—Losartan—type 2 diabetes mellitus	0.000342	0.00164	CcSEcCtD
Thiabendazole—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000341	0.00164	CcSEcCtD
Thiabendazole—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000341	0.00164	CcSEcCtD
Thiabendazole—Vision blurred—Metformin—type 2 diabetes mellitus	0.00034	0.00163	CcSEcCtD
Thiabendazole—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00034	0.00163	CcSEcCtD
Thiabendazole—Convulsion—Orlistat—type 2 diabetes mellitus	0.00034	0.00163	CcSEcCtD
Thiabendazole—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000339	0.00163	CcSEcCtD
Thiabendazole—Dizziness—Glipizide—type 2 diabetes mellitus	0.000337	0.00162	CcSEcCtD
Thiabendazole—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000337	0.00161	CcSEcCtD
Thiabendazole—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000334	0.0016	CcSEcCtD
Thiabendazole—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000329	0.00158	CcSEcCtD
Thiabendazole—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000326	0.00156	CcSEcCtD
Thiabendazole—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000325	0.00156	CcSEcCtD
Thiabendazole—Vomiting—Glipizide—type 2 diabetes mellitus	0.000324	0.00155	CcSEcCtD
Thiabendazole—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000324	0.00155	CcSEcCtD
Thiabendazole—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000323	0.00155	CcSEcCtD
Thiabendazole—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000323	0.00155	CcSEcCtD
Thiabendazole—Rash—Glipizide—type 2 diabetes mellitus	0.000322	0.00154	CcSEcCtD
Thiabendazole—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000321	0.00154	CcSEcCtD
Thiabendazole—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000321	0.00154	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000321	0.00154	CcSEcCtD
Thiabendazole—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00032	0.00153	CcSEcCtD
Thiabendazole—Headache—Glipizide—type 2 diabetes mellitus	0.000319	0.00153	CcSEcCtD
Thiabendazole—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000315	0.00151	CcSEcCtD
Thiabendazole—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000314	0.0015	CcSEcCtD
Thiabendazole—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000313	0.0015	CcSEcCtD
Thiabendazole—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000312	0.00149	CcSEcCtD
Thiabendazole—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00031	0.00149	CcSEcCtD
Thiabendazole—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00031	0.00149	CcSEcCtD
Thiabendazole—Anorexia—Valsartan—type 2 diabetes mellitus	0.000309	0.00148	CcSEcCtD
Thiabendazole—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000308	0.00148	CcSEcCtD
Thiabendazole—Headache—Pioglitazone—type 2 diabetes mellitus	0.000306	0.00147	CcSEcCtD
Thiabendazole—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000305	0.00146	CcSEcCtD
Thiabendazole—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000305	0.00146	CcSEcCtD
Thiabendazole—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000304	0.00146	CcSEcCtD
Thiabendazole—Nausea—Glipizide—type 2 diabetes mellitus	0.000303	0.00145	CcSEcCtD
Thiabendazole—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000303	0.00145	CcSEcCtD
Thiabendazole—Hypotension—Valsartan—type 2 diabetes mellitus	0.000303	0.00145	CcSEcCtD
Thiabendazole—Vision blurred—Losartan—type 2 diabetes mellitus	0.000302	0.00145	CcSEcCtD
Thiabendazole—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000302	0.00145	CcSEcCtD
Thiabendazole—Rash—Glimepiride—type 2 diabetes mellitus	0.0003	0.00144	CcSEcCtD
Thiabendazole—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.0003	0.00144	CcSEcCtD
Thiabendazole—Rash—Sitagliptin—type 2 diabetes mellitus	0.000299	0.00143	CcSEcCtD
Thiabendazole—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000299	0.00143	CcSEcCtD
Thiabendazole—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000299	0.00143	CcSEcCtD
Thiabendazole—Headache—Glimepiride—type 2 diabetes mellitus	0.000298	0.00143	CcSEcCtD
Thiabendazole—Headache—Sitagliptin—type 2 diabetes mellitus	0.000297	0.00142	CcSEcCtD
Thiabendazole—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000295	0.00141	CcSEcCtD
Thiabendazole—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000294	0.00141	CcSEcCtD
Thiabendazole—Flushing—Ramipril—type 2 diabetes mellitus	0.000293	0.00141	CcSEcCtD
Thiabendazole—Angioedema—Losartan—type 2 diabetes mellitus	0.000293	0.00141	CcSEcCtD
Thiabendazole—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00029	0.00139	CcSEcCtD
Thiabendazole—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000289	0.00139	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000288	0.00138	CcSEcCtD
Thiabendazole—Somnolence—Valsartan—type 2 diabetes mellitus	0.000288	0.00138	CcSEcCtD
Thiabendazole—Leukopenia—Losartan—type 2 diabetes mellitus	0.000287	0.00138	CcSEcCtD
Thiabendazole—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000285	0.00137	CcSEcCtD
Thiabendazole—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000284	0.00136	CcSEcCtD
Thiabendazole—Nausea—Glimepiride—type 2 diabetes mellitus	0.000283	0.00136	CcSEcCtD
Thiabendazole—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000282	0.00135	CcSEcCtD
Thiabendazole—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000282	0.00135	CcSEcCtD
Thiabendazole—Asthenia—Glyburide—type 2 diabetes mellitus	0.000282	0.00135	CcSEcCtD
Thiabendazole—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000281	0.00135	CcSEcCtD
Thiabendazole—Anorexia—Metformin—type 2 diabetes mellitus	0.000281	0.00135	CcSEcCtD
Thiabendazole—Fatigue—Valsartan—type 2 diabetes mellitus	0.000279	0.00134	CcSEcCtD
Thiabendazole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000279	0.00134	CcSEcCtD
Thiabendazole—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000278	0.00133	CcSEcCtD
Thiabendazole—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000278	0.00133	CcSEcCtD
Thiabendazole—Pruritus—Glyburide—type 2 diabetes mellitus	0.000278	0.00133	CcSEcCtD
Thiabendazole—Fatigue—Orlistat—type 2 diabetes mellitus	0.000276	0.00132	CcSEcCtD
Thiabendazole—Hypotension—Metformin—type 2 diabetes mellitus	0.000276	0.00132	CcSEcCtD
Thiabendazole—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000273	0.00131	CcSEcCtD
Thiabendazole—Rash—Bromocriptine—type 2 diabetes mellitus	0.000271	0.0013	CcSEcCtD
Thiabendazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00027	0.0013	CcSEcCtD
Thiabendazole—Headache—Bromocriptine—type 2 diabetes mellitus	0.000269	0.00129	CcSEcCtD
Thiabendazole—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000269	0.00129	CcSEcCtD
Thiabendazole—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000265	0.00127	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000265	0.00127	CcSEcCtD
Thiabendazole—Confusional state—Losartan—type 2 diabetes mellitus	0.000264	0.00127	CcSEcCtD
Thiabendazole—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000264	0.00126	CcSEcCtD
Thiabendazole—Somnolence—Metformin—type 2 diabetes mellitus	0.000262	0.00126	CcSEcCtD
Thiabendazole—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000262	0.00126	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000262	0.00125	CcSEcCtD
Thiabendazole—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00026	0.00125	CcSEcCtD
Thiabendazole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00026	0.00124	CcSEcCtD
Thiabendazole—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00026	0.00124	CcSEcCtD
Thiabendazole—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000256	0.00123	CcSEcCtD
Thiabendazole—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000256	0.00123	CcSEcCtD
Thiabendazole—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000255	0.00122	CcSEcCtD
Thiabendazole—Fatigue—Metformin—type 2 diabetes mellitus	0.000254	0.00122	CcSEcCtD
Thiabendazole—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000253	0.00121	CcSEcCtD
Thiabendazole—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000253	0.00121	CcSEcCtD
Thiabendazole—Angioedema—Ramipril—type 2 diabetes mellitus	0.000251	0.00121	CcSEcCtD
Thiabendazole—Anorexia—Losartan—type 2 diabetes mellitus	0.00025	0.0012	CcSEcCtD
Thiabendazole—Vomiting—Glyburide—type 2 diabetes mellitus	0.00025	0.0012	CcSEcCtD
Thiabendazole—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000249	0.0012	CcSEcCtD
Thiabendazole—Rash—Glyburide—type 2 diabetes mellitus	0.000247	0.00119	CcSEcCtD
Thiabendazole—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000247	0.00119	CcSEcCtD
Thiabendazole—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000247	0.00119	CcSEcCtD
Thiabendazole—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000246	0.00118	CcSEcCtD
Thiabendazole—Headache—Glyburide—type 2 diabetes mellitus	0.000246	0.00118	CcSEcCtD
Thiabendazole—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000245	0.00117	CcSEcCtD
Thiabendazole—Hypotension—Losartan—type 2 diabetes mellitus	0.000245	0.00117	CcSEcCtD
Thiabendazole—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000243	0.00116	CcSEcCtD
Thiabendazole—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000242	0.00116	CcSEcCtD
Thiabendazole—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000241	0.00116	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000241	0.00116	CcSEcCtD
Thiabendazole—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00024	0.00115	CcSEcCtD
Thiabendazole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000239	0.00114	CcSEcCtD
Thiabendazole—Convulsion—Ramipril—type 2 diabetes mellitus	0.000238	0.00114	CcSEcCtD
Thiabendazole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000236	0.00113	CcSEcCtD
Thiabendazole—Nausea—Glyburide—type 2 diabetes mellitus	0.000233	0.00112	CcSEcCtD
Thiabendazole—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000233	0.00112	CcSEcCtD
Thiabendazole—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000233	0.00112	CcSEcCtD
Thiabendazole—Somnolence—Losartan—type 2 diabetes mellitus	0.000233	0.00112	CcSEcCtD
Thiabendazole—Asthenia—Valsartan—type 2 diabetes mellitus	0.000232	0.00111	CcSEcCtD
Thiabendazole—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000231	0.0011	CcSEcCtD
Thiabendazole—Asthenia—Orlistat—type 2 diabetes mellitus	0.00023	0.0011	CcSEcCtD
Thiabendazole—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000229	0.0011	CcSEcCtD
Thiabendazole—Pruritus—Valsartan—type 2 diabetes mellitus	0.000229	0.0011	CcSEcCtD
Thiabendazole—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000228	0.00109	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000228	0.00109	CcSEcCtD
Thiabendazole—Confusional state—Ramipril—type 2 diabetes mellitus	0.000226	0.00109	CcSEcCtD
Thiabendazole—Pruritus—Orlistat—type 2 diabetes mellitus	0.000226	0.00109	CcSEcCtD
Thiabendazole—Fatigue—Losartan—type 2 diabetes mellitus	0.000226	0.00108	CcSEcCtD
Thiabendazole—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000225	0.00108	CcSEcCtD
Thiabendazole—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000224	0.00107	CcSEcCtD
Thiabendazole—Rash—Gliclazide—type 2 diabetes mellitus	0.000222	0.00107	CcSEcCtD
Thiabendazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000222	0.00106	CcSEcCtD
Thiabendazole—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000222	0.00106	CcSEcCtD
Thiabendazole—Headache—Gliclazide—type 2 diabetes mellitus	0.000221	0.00106	CcSEcCtD
Thiabendazole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00022	0.00105	CcSEcCtD
Thiabendazole—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000219	0.00105	CcSEcCtD
Thiabendazole—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000216	0.00103	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000214	0.00103	CcSEcCtD
Thiabendazole—Dizziness—Valsartan—type 2 diabetes mellitus	0.000214	0.00103	CcSEcCtD
Thiabendazole—Anorexia—Ramipril—type 2 diabetes mellitus	0.000214	0.00103	CcSEcCtD
Thiabendazole—Dizziness—Orlistat—type 2 diabetes mellitus	0.000212	0.00101	CcSEcCtD
Thiabendazole—Asthenia—Metformin—type 2 diabetes mellitus	0.000212	0.00101	CcSEcCtD
Thiabendazole—Hypotension—Ramipril—type 2 diabetes mellitus	0.00021	0.00101	CcSEcCtD
Thiabendazole—Nausea—Gliclazide—type 2 diabetes mellitus	0.000209	0.001	CcSEcCtD
Thiabendazole—Pruritus—Metformin—type 2 diabetes mellitus	0.000209	0.001	CcSEcCtD
Thiabendazole—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000207	0.000992	CcSEcCtD
Thiabendazole—Vomiting—Valsartan—type 2 diabetes mellitus	0.000206	0.000987	CcSEcCtD
Thiabendazole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000205	0.000983	CcSEcCtD
Thiabendazole—Rash—Valsartan—type 2 diabetes mellitus	0.000204	0.000979	CcSEcCtD
Thiabendazole—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000204	0.000978	CcSEcCtD
Thiabendazole—Vomiting—Orlistat—type 2 diabetes mellitus	0.000203	0.000975	CcSEcCtD
Thiabendazole—Headache—Valsartan—type 2 diabetes mellitus	0.000203	0.000972	CcSEcCtD
Thiabendazole—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000202	0.000967	CcSEcCtD
Thiabendazole—Rash—Orlistat—type 2 diabetes mellitus	0.000202	0.000967	CcSEcCtD
Thiabendazole—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000202	0.000966	CcSEcCtD
Thiabendazole—Headache—Orlistat—type 2 diabetes mellitus	0.0002	0.000961	CcSEcCtD
Thiabendazole—Asthenia—Irbesartan—type 2 diabetes mellitus	0.0002	0.000957	CcSEcCtD
Thiabendazole—Somnolence—Ramipril—type 2 diabetes mellitus	0.0002	0.000957	CcSEcCtD
Thiabendazole—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000198	0.000947	CcSEcCtD
Thiabendazole—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000197	0.000944	CcSEcCtD
Thiabendazole—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000195	0.000936	CcSEcCtD
Thiabendazole—Dizziness—Metformin—type 2 diabetes mellitus	0.000195	0.000935	CcSEcCtD
Thiabendazole—Fatigue—Ramipril—type 2 diabetes mellitus	0.000194	0.000928	CcSEcCtD
Thiabendazole—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000193	0.000925	CcSEcCtD
Thiabendazole—Nausea—Valsartan—type 2 diabetes mellitus	0.000192	0.000922	CcSEcCtD
Thiabendazole—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00019	0.000913	CcSEcCtD
Thiabendazole—Nausea—Orlistat—type 2 diabetes mellitus	0.00019	0.000911	CcSEcCtD
Thiabendazole—Asthenia—Losartan—type 2 diabetes mellitus	0.000188	0.000901	CcSEcCtD
Thiabendazole—Vomiting—Metformin—type 2 diabetes mellitus	0.000187	0.000899	CcSEcCtD
Thiabendazole—Rash—Metformin—type 2 diabetes mellitus	0.000186	0.000891	CcSEcCtD
Thiabendazole—Dermatitis—Metformin—type 2 diabetes mellitus	0.000186	0.00089	CcSEcCtD
Thiabendazole—Pruritus—Losartan—type 2 diabetes mellitus	0.000185	0.000888	CcSEcCtD
Thiabendazole—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000185	0.000887	CcSEcCtD
Thiabendazole—Headache—Metformin—type 2 diabetes mellitus	0.000185	0.000885	CcSEcCtD
Thiabendazole—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000184	0.000882	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000184	0.00088	CcSEcCtD
Thiabendazole—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000179	0.000859	CcSEcCtD
Thiabendazole—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000178	0.000851	CcSEcCtD
Thiabendazole—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000177	0.000848	CcSEcCtD
Thiabendazole—Rash—Irbesartan—type 2 diabetes mellitus	0.000175	0.000841	CcSEcCtD
Thiabendazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000175	0.00084	CcSEcCtD
Thiabendazole—Nausea—Metformin—type 2 diabetes mellitus	0.000175	0.00084	CcSEcCtD
Thiabendazole—Headache—Irbesartan—type 2 diabetes mellitus	0.000174	0.000836	CcSEcCtD
Thiabendazole—Dizziness—Losartan—type 2 diabetes mellitus	0.000173	0.00083	CcSEcCtD
Thiabendazole—Vomiting—Losartan—type 2 diabetes mellitus	0.000166	0.000798	CcSEcCtD
Thiabendazole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000165	0.000793	CcSEcCtD
Thiabendazole—Nausea—Irbesartan—type 2 diabetes mellitus	0.000165	0.000792	CcSEcCtD
Thiabendazole—Rash—Losartan—type 2 diabetes mellitus	0.000165	0.000791	CcSEcCtD
Thiabendazole—Dermatitis—Losartan—type 2 diabetes mellitus	0.000165	0.000791	CcSEcCtD
Thiabendazole—Headache—Losartan—type 2 diabetes mellitus	0.000164	0.000786	CcSEcCtD
Thiabendazole—Asthenia—Ramipril—type 2 diabetes mellitus	0.000161	0.000772	CcSEcCtD
Thiabendazole—Pruritus—Ramipril—type 2 diabetes mellitus	0.000159	0.000761	CcSEcCtD
Thiabendazole—Nausea—Losartan—type 2 diabetes mellitus	0.000156	0.000746	CcSEcCtD
Thiabendazole—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000154	0.000736	CcSEcCtD
Thiabendazole—Dizziness—Ramipril—type 2 diabetes mellitus	0.000148	0.000712	CcSEcCtD
Thiabendazole—Vomiting—Ramipril—type 2 diabetes mellitus	0.000143	0.000684	CcSEcCtD
Thiabendazole—Rash—Ramipril—type 2 diabetes mellitus	0.000142	0.000679	CcSEcCtD
Thiabendazole—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000141	0.000678	CcSEcCtD
Thiabendazole—Headache—Ramipril—type 2 diabetes mellitus	0.000141	0.000674	CcSEcCtD
Thiabendazole—Nausea—Ramipril—type 2 diabetes mellitus	0.000133	0.000639	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—type 2 diabetes mellitus	8.33e-05	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	8.27e-05	0.00137	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	8.27e-05	0.00137	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	8.27e-05	0.00137	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—PPARG—type 2 diabetes mellitus	8.26e-05	0.00137	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP11A1—type 2 diabetes mellitus	8.22e-05	0.00136	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	8.11e-05	0.00134	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—type 2 diabetes mellitus	8.09e-05	0.00134	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTM1—type 2 diabetes mellitus	8.06e-05	0.00134	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	7.95e-05	0.00132	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	7.79e-05	0.00129	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	7.7e-05	0.00128	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	7.5e-05	0.00124	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	7.37e-05	0.00122	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	7.3e-05	0.00121	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—type 2 diabetes mellitus	7.25e-05	0.0012	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—type 2 diabetes mellitus	7.23e-05	0.0012	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2E1—type 2 diabetes mellitus	6.78e-05	0.00112	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—type 2 diabetes mellitus	6.74e-05	0.00112	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—type 2 diabetes mellitus	6.73e-05	0.00112	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—SRC—type 2 diabetes mellitus	6.73e-05	0.00112	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	6.69e-05	0.00111	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—type 2 diabetes mellitus	6.56e-05	0.00109	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP3A4—type 2 diabetes mellitus	6.54e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—type 2 diabetes mellitus	6.53e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	6.45e-05	0.00107	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—type 2 diabetes mellitus	6.32e-05	0.00105	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	6.27e-05	0.00104	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	6.27e-05	0.00104	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—BHMT—type 2 diabetes mellitus	6.15e-05	0.00102	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—type 2 diabetes mellitus	6.02e-05	0.000998	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 2 diabetes mellitus	5.9e-05	0.000979	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 2 diabetes mellitus	5.9e-05	0.000979	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	5.67e-05	0.000941	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 2 diabetes mellitus	5.62e-05	0.000932	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 2 diabetes mellitus	5.62e-05	0.000932	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—type 2 diabetes mellitus	5.57e-05	0.000924	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	5.53e-05	0.000917	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AANAT—type 2 diabetes mellitus	5.38e-05	0.000891	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGDS—type 2 diabetes mellitus	5.38e-05	0.000891	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	5.27e-05	0.000875	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	5.27e-05	0.000875	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	5.27e-05	0.000875	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTM1—type 2 diabetes mellitus	5.14e-05	0.000852	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	5.11e-05	0.000847	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CDO1—type 2 diabetes mellitus	5.1e-05	0.000845	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GPD2—type 2 diabetes mellitus	5.1e-05	0.000845	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	5.07e-05	0.000841	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.98e-05	0.000826	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.95e-05	0.000821	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AK1—type 2 diabetes mellitus	4.86e-05	0.000806	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	4.81e-05	0.000797	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	4.78e-05	0.000793	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	4.7e-05	0.00078	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC5A4—type 2 diabetes mellitus	4.49e-05	0.000744	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MAT1A—type 2 diabetes mellitus	4.49e-05	0.000744	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	4.47e-05	0.000741	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	4.38e-05	0.000727	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	4.35e-05	0.000721	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.33e-05	0.000718	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ENPP1—type 2 diabetes mellitus	4.33e-05	0.000718	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ND1—type 2 diabetes mellitus	4.33e-05	0.000718	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—G6PC—type 2 diabetes mellitus	4.33e-05	0.000718	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HBA2—type 2 diabetes mellitus	4.33e-05	0.000718	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GCGR—type 2 diabetes mellitus	4.2e-05	0.000696	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	4.04e-05	0.00067	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	4e-05	0.000663	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	4e-05	0.000663	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYTB—type 2 diabetes mellitus	3.96e-05	0.000657	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—OXCT1—type 2 diabetes mellitus	3.96e-05	0.000657	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—BHMT—type 2 diabetes mellitus	3.92e-05	0.00065	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SRD5A1—type 2 diabetes mellitus	3.86e-05	0.00064	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—STAR—type 2 diabetes mellitus	3.68e-05	0.000611	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD17B3—type 2 diabetes mellitus	3.68e-05	0.000611	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ACACA—type 2 diabetes mellitus	3.68e-05	0.000611	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCC8—type 2 diabetes mellitus	3.53e-05	0.000586	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CBS—type 2 diabetes mellitus	3.53e-05	0.000586	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	3.43e-05	0.000568	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	3.43e-05	0.000568	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—COX2—type 2 diabetes mellitus	3.4e-05	0.000564	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC5A2—type 2 diabetes mellitus	3.4e-05	0.000564	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOA6—type 2 diabetes mellitus	3.34e-05	0.000554	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.34e-05	0.000554	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—UCP3—type 2 diabetes mellitus	3.28e-05	0.000544	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD11B1—type 2 diabetes mellitus	3.28e-05	0.000544	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—UCP2—type 2 diabetes mellitus	3.28e-05	0.000544	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	3.26e-05	0.00054	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	3.25e-05	0.000539	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	3.25e-05	0.000539	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	3.18e-05	0.000528	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	3.18e-05	0.000527	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	3.16e-05	0.000523	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	3.1e-05	0.000514	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PCK1—type 2 diabetes mellitus	3.09e-05	0.000512	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	3.06e-05	0.000508	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	3.04e-05	0.000504	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.97e-05	0.000492	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HK1—type 2 diabetes mellitus	2.89e-05	0.000479	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.89e-05	0.000479	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	2.86e-05	0.000474	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	2.86e-05	0.000474	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.85e-05	0.000472	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.8e-05	0.000464	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GCKR—type 2 diabetes mellitus	2.79e-05	0.000463	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—KCNJ11—type 2 diabetes mellitus	2.79e-05	0.000463	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD3B2—type 2 diabetes mellitus	2.79e-05	0.000463	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LPA—type 2 diabetes mellitus	2.79e-05	0.000463	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.77e-05	0.000459	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	2.76e-05	0.000458	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.76e-05	0.000458	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	2.76e-05	0.000458	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	2.76e-05	0.000458	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	2.76e-05	0.000458	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.68e-05	0.000445	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALDOB—type 2 diabetes mellitus	2.68e-05	0.000444	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	2.68e-05	0.000444	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.6e-05	0.000431	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.55e-05	0.000422	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	2.53e-05	0.000419	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	2.53e-05	0.000419	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.52e-05	0.000418	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GLP1R—type 2 diabetes mellitus	2.49e-05	0.000413	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	2.46e-05	0.000408	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	2.35e-05	0.000389	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	2.35e-05	0.000389	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	2.35e-05	0.000389	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.32e-05	0.000385	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CPT1A—type 2 diabetes mellitus	2.28e-05	0.000377	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTR—type 2 diabetes mellitus	2.28e-05	0.000377	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	2.25e-05	0.000373	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	2.25e-05	0.000373	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NAMPT—type 2 diabetes mellitus	2.23e-05	0.00037	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.22e-05	0.000368	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HBA1—type 2 diabetes mellitus	2.22e-05	0.000368	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LIPC—type 2 diabetes mellitus	2.22e-05	0.000368	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GCK—type 2 diabetes mellitus	2.22e-05	0.000368	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.2e-05	0.000365	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	2.17e-05	0.000359	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	2.17e-05	0.000359	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.16e-05	0.000359	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CETP—type 2 diabetes mellitus	2.14e-05	0.000355	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	2.13e-05	0.000353	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.13e-05	0.000353	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	2.09e-05	0.000347	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	2.09e-05	0.000347	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	2.09e-05	0.000347	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.03e-05	0.000337	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2e-05	0.000331	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SREBF1—type 2 diabetes mellitus	1.99e-05	0.00033	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SNAP25—type 2 diabetes mellitus	1.99e-05	0.00033	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PSMD6—type 2 diabetes mellitus	1.99e-05	0.00033	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	1.97e-05	0.000326	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CTGF—type 2 diabetes mellitus	1.95e-05	0.000324	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.94e-05	0.000321	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMGCR—type 2 diabetes mellitus	1.94e-05	0.000321	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.91e-05	0.000316	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.89e-05	0.000314	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.89e-05	0.000313	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	1.84e-05	0.000306	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.84e-05	0.000305	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.82e-05	0.000302	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.8e-05	0.000298	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.8e-05	0.000298	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	1.78e-05	0.000295	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.78e-05	0.000295	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.78e-05	0.000295	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	1.78e-05	0.000295	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.75e-05	0.000291	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.75e-05	0.000289	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	1.72e-05	0.000286	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.72e-05	0.000286	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.71e-05	0.000284	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	1.71e-05	0.000283	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.66e-05	0.000275	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.62e-05	0.000269	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.61e-05	0.000266	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	1.59e-05	0.000263	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	1.49e-05	0.000247	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.49e-05	0.000247	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.48e-05	0.000246	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.48e-05	0.000245	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	1.46e-05	0.000242	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	1.45e-05	0.000241	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	1.45e-05	0.000241	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	1.42e-05	0.000236	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	1.42e-05	0.000235	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.41e-05	0.000235	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	1.41e-05	0.000234	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	1.41e-05	0.000234	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	1.41e-05	0.000234	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.41e-05	0.000233	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.38e-05	0.000229	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.38e-05	0.000229	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	1.36e-05	0.000226	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	1.35e-05	0.000224	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.33e-05	0.00022	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	1.32e-05	0.000219	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	1.29e-05	0.000213	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.27e-05	0.000211	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.27e-05	0.000211	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	1.27e-05	0.00021	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	1.27e-05	0.00021	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	1.27e-05	0.00021	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	1.25e-05	0.000206	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	1.23e-05	0.000205	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.22e-05	0.000202	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.22e-05	0.000202	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.21e-05	0.0002	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	1.2e-05	0.000198	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.16e-05	0.000192	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	1.16e-05	0.000192	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.15e-05	0.00019	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	1.14e-05	0.000189	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	1.13e-05	0.000188	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	1.12e-05	0.000186	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.12e-05	0.000185	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.11e-05	0.000185	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	1.1e-05	0.000182	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.1e-05	0.000182	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	9.88e-06	0.000164	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	9.69e-06	0.000161	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	9.48e-06	0.000157	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.48e-06	0.000157	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	9.44e-06	0.000156	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	9.31e-06	0.000154	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	9.04e-06	0.00015	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	8.89e-06	0.000147	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	8.79e-06	0.000146	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	8.63e-06	0.000143	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.5e-06	0.000141	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	8.5e-06	0.000141	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	8.45e-06	0.00014	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	8.42e-06	0.00014	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	8.2e-06	0.000136	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	8.1e-06	0.000134	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	7.77e-06	0.000129	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	7.77e-06	0.000129	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	7.62e-06	0.000126	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	7.38e-06	0.000122	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	7.26e-06	0.00012	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	7.23e-06	0.00012	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	7.15e-06	0.000119	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	6.3e-06	0.000104	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	6.18e-06	0.000102	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	5.67e-06	9.39e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	5.42e-06	8.99e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	5.42e-06	8.99e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	4.96e-06	8.22e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	3.91e-06	6.48e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.49e-06	4.13e-05	CbGpPWpGaD
